Antithrombotic Therapy in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary PCI

Antithrombotic Therapy in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary PCI

Ischemic heart disease is one of the most prevalent diseases with a high impact on mortality and morbidity. The main process implicated in acute coronary syndromes (ACS) including its most severe form, the ST elevation myocardial infarction (STEMI), is the development of thrombosis subsequently of p...

Full description

Bibliographic Details
Main Authors: VLAD BATAILA, NICOLETA POPA-FOTEA, SEBASTIAN ONCIUL, LUCIAN CALMAC, ALEXANDRU SCAFA-UDRISTE, ALI CHERRY, DIANA STANCIULESCU, MARIA DOROBANTU
Format: Article
Language:English
Published: Media Med Publicis 2019-09-01
Series:Modern Medicine
Subjects:
stemi
acute coronary syndromes
antiplatelets
anticoagulants
guidelines
risk-benefi t balance
Online Access:https://medicinamoderna.ro/wp-content/uploads/2019/09/Antithrombotic-Therapy-in-Patients-with-ST-segment-Elevation-Myocardial-Infarction-Undergoing-Primary-PCI.pdf

Internet

https://medicinamoderna.ro/wp-content/uploads/2019/09/Antithrombotic-Therapy-in-Patients-with-ST-segment-Elevation-Myocardial-Infarction-Undergoing-Primary-PCI.pdf

Similar Items